Products
Curatis is passionate about specialist health care professionals being able to treat patients who have rare diseases, specialty care diseases and intoxications and securing the availability of important novel and established essential medicines in Switzerland. Curatis markets and distributes its own products as well as products from international partner companies.
Please see below for more information about our products.
Products A to Z | Field of Application | SPC* | PIL** |
---|---|---|---|
Aggrastat® (Tirofiban) | Antiplatelet | SPC | |
AmbiFul® (Fulvestrant) | Metastatic hormone receptor-positive breast cancer | SPC | |
Brinavess® (Vernakalant) | Anti-arrhythmic | SPC | |
Coldistop® | Nasal oil | SPC | PIL |
Cuprior® (Trientin) | Wilson’s disease | SPC | PIL |
Cyanokit® (Hydroxocobalamin) | Cyanide poisoning | SPC | |
DigiFab® (Digoxin Immune FAB) | Digoxin toxicity | SPC | |
Effortil (Etilefrinhydrochlorid) | Antihypotensive | SPC | PIL |
elmiron® (Pentosan Polysulfate) | Bladder pain syndrome/intersticial cystitis | SPC | PIL |
Erythrocin® (Erythromycin) | Antibioticum | SPC | |
Fluoresceine 0,5% | Diagnostic ophthalmology | SPC | |
Fluoresceine 10% | Diagnostic ophthalmology | SPC | |
Foscavir® (Foscarnet) | Antiviral | SPC | |
Fucithalmic® (Fusidic acid) | Ophtalmic/ Antibioticum | SPC | PIL |
Garamycin® Schwamm | Gentamycin collagen sponge | SPC | |
Hytrin® BPH (Terazosinum) | Benign prostatic hyperplasia | SPC | PIL |
Imukin® (human Interferon gamma 1b) | Immunomodulator | SPC | |
Mysoline® (Primidone) | Treatment of various forms of epilepsy and essential tremor | SPC | PIL |
Néo-Mercazole® (Carbimazolum) | Thyreostatic | SPC | PIL |
Nityr® (Nitisinon) | Hereditary tyrosinemia type 1 | SPC | PIL |
Ocaliva® (Obeticholic acid) | Gastroenterologic | SPC | PIL |
Proleukin ® (Aldesleukine) | Immunomodulator | SPC | |
Propycil® (Propylthiouracil) | Thyreostatic | SPC | PIL |
Psychopax® (liquid formulation of Diazepam) | Tranquilizer | SPC | PIL |
Pylori 13 | Helicobacter pylori test | SPC | |
Renacet (Calcium Acetate) | Phosphate binder | SPC | PIL |
Renapro, Renergy | Special nutrition for dialysis patients | PI*** | |
Sicorten® (Halometasonum, Triclonasum) | Dermato corticosteroid | SPC | PIL |
Succicaptal® (Succimer) | Treatment of lead and mercury poisoning | SPC | |
Synacthen® (Tetracosactidum) | Corticostimulin | SPC | |
ULTRASTOP®, ULTRASTOP® pro med | Anti-fog agent | PIL | |
Xenazine® (Tetrabenazine) | Treatment of chorea associated with Huntington’s disease | SPC | PIL |
Zonegran® (Zonisamid) | Antiepileptic | SPC | PIL |
*SPC: Summary of Product Characteristics
**PIL: Patient Insert Leaflet
***PI: Product Information
Commercial partnerships for Switzerland
Curatis is your partner company of choice for your products in Switzerland.
Customised and efficient partnership
Curatis is keen to offer its partners a customised package for the commercialisation of pharmaceutical products in Switzerland, taking into account the specific needs and requirements of the partner company and its product(s).
Curatis core competencies
- specialty care drugs, orphan drugs as well as antidotes
- market access (registration, pricing and reimbursement)
- marketing and sales activities for specialised products
- early access programmes
- state-of-the-art quality and pharmacovigilance know-how
- efficient and fast operational processes and communication with partners
- accommodation and implementation of partner-specific requirements
Commercial partnerships for Germany, France, Italy and UK
In line with the company’s geographic expansion strategy, Curatis is also looking for distribution partnerships for ultra orphan, orphan and specialty care medicines for Germany, France, Italy and UK.
For more information, please contact us at info(at)curatis.com